We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-16.99%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$505K
AUM Growth
–
Cap. Flow
+$533K
Cap. Flow %
105.42%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
KRSA
Korsana Biosciences, Inc. Common Stock
KRSA
+$533K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KRSA
1
Korsana Biosciences, Inc. Common Stock
KRSA
$1.54B
$505K 100%
+21,102
New +$533K
2023 Q3
0 quarters

Similar funds

Tyndall Capital Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Tyndall Capital Partners held 1 position worth $505K. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners deployed $533K of net new capital in Q3 2023, opening 1 new position. Its largest new stake was Korsana Biosciences, Inc. Common Stock: 21,102 shares worth $505K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Tyndall Capital Partners's largest Q3 2023 buy was Korsana Biosciences, Inc. Common Stock: 21,102 shares worth $505K.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $505K portfolio in Q3 2023.
  • Tyndall Capital Partners opened 1 new position and closed 0 in Q3 2023.

Based on Tyndall Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.